Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Cardiovascular effects associated with acute recreational drug toxicity presentations to the emergency department: a European drug emergencies network (Euro-DEN plus) study.Clinical toxicology (Philadelphia, Pa.) · 2026-06-22Structural plasticity and enhanced fear extinction following psilocybin in chronically stressed micebioRxiv · 2026-04-21The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-03-22Synthesis and Characterization of Psilocybin Metabolites and Deuterated AnalogsACS Chemical Neuroscience · 2026-03-02The impact of COMP360 psilocybin on anhedonia: post-hoc analyses from a phase IIb randomised controlled trialNeuroscience Applied · 2025-12-31Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic ResearchPsychedelic Medicine · 2025-12-18Preadministration of Lorazepam Negates the Long-Term Antidepressant-Like Effects of Psilocybin in Male Wistar Kyoto RatsPsychedelic Medicine · 2025-12-15Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].Unknown journal · 2025-10-09Publisher Correction: Psilocybin's lasting action requires pyramidal cell types and 5-HT2A receptors.Nature · 2025-09-30Synthesis of Psilocin, Psilocybin and 5-MeO-DMT Succinate, All Labelled With Carbon-14 at the Indole 2-PositionJournal of Labelled Compounds and Radiopharmaceuticals · 2025-06-30In Vitro Psilocybin Synthesis by Co-Immobilized EnzymesChemistry - A European Journal · 2025-04-08Psilocybin’s lasting action requires pyramidal cell types and 5-HT2A receptorsNature · 2025-04-01Psilocybin mushrooms (“Magic Mushrooms”)Organization of Teratology Information Specialists (OTIS), Brentwood (TN) · 2025-03-31Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive DisorderThe Journal of Clinical Psychiatry · 2025-03-02Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake ratsbioRxiv · 2025-02-05Psilocybin as a Treatment for Repetitive Mild Head Injury: Evidence from Neuroradiology and Molecular BiologybioRxiv · 2025-02-05The role of the psychedelic experience in psilocybin treatment for treatment-resistant depressionJournal of Affective Disorders · 2024-12-17Pyramidal cell types and 5-HT2A receptors are essential for psilocybin’s lasting drug actionbioRxiv · 2024-11-02The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depressionJournal of Psychiatric Research · 2024-10-10Refractory CRPS pain treated with psilocybin: A case reportClinical Case Reports · 2024-08-31Classification of psychedelics and psychoactive drugs based on brain-wide imaging of cellular c-Fos expressionbioRxiv · 2024-05-25Psilocybin facilitates fear extinction: importance of dose, context, and serotonin receptorsbioRxiv · 2024-05-05At the Forefront: Social Workers’ Role in Psilocybin Treatment for Depression and Substance MisuseSocial Work · 2024-05-01Screening and confirmation of psilocin, mitragynine, phencyclidine, ketamine and ketamine metabolites by liquid chromatography-tandem mass spectrometry.Unknown journal · 2024-02-29Quantification of psilocin in human whole blood using liquid chromatography-tandem mass spectrometry (LC-MS/MS)Journal of Forensic Sciences · 2023-12-21Improvement in Depression Symptoms Measured by Montgomery-Åsberg Depression Rating Scale and Quick Inventory of Depressive Symptomatology-Self Rated Items after Randomised Double-blind COMP360 Psilocybin Therapy for Treatment-resistant DepressionUnknown journal · 2023-07-18Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medicationNeuropsychopharmacology · 2023-07-12Unblinding and demand characteristics in the treatment of depression.Journal of affective disorders · 2023-04-30Psychedelic Sensationalism: An Analysis of the Schedule Classification of PsilocybinVanderbilt Undergraduate Research Journal · 2023-04-23Psychotherapy with Psilocybin for Depression: Systematic Review.Unknown journal · 2023-03-30Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of lifeJournal of Affective Disorders · 2023-02-02The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a long-term observational follow-up studyNeuroscience Applied · 2022-12-31Withdrawal of antidepressants does not impact the efficacy of COMP360 psilocybin therapy: results from a phase IIb randomised controlled trialNeuroscience Applied · 2022-12-315-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in micebioRxiv · 2022-11-02Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice.ACS Pharmacology & Translational Science · 2022-11-01Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-16Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examplesActa Crystallographica Section A Foundations and Advances · 2022-07-28Assessment of Bioactivity-Modulating Pseudo-Ring Formation in Psilocin and Related Tryptamines.ChemBioChem · 2022-05-17Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex.NeuroImage · 2022-04-24Psilocybin: Characterization of the Metastable Zone Width (MSZW), Control of Anhydrous Polymorphs, and Particle Size Distribution (PSD).ACS Omega · 2022-02-06The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.Journal of Psychopharmacology · 2022-01-03The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trialNeuroscience Applied · 2021-12-31The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trialNeuroscience Applied · 2021-12-31Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examples.Acta Crystallographica Section C Structural Chemistry · 2021-12-31Structure Elucidation and Spectroscopic Analysis of Chromophores Produced by Oxidative Psilocin Dimerization.Chemistry - A European Journal · 2021-07-05Chemoenzymatic Synthesis of 5-Methylpsilocybin: A Tryptamine with Potential Psychedelic Activity.Journal of Natural Products · 2021-03-04Taking Different Roads: l-Tryptophan as the Origin of Psilocybe Natural Products.Unknown journal · 2020-11-24Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of PsilocybinACS Omega · 2020-06-30Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortexbioRxiv · 2020-05-02Scalable Hybrid Synthetic/Biocatalytic Route to PsilocybinChemistry - A European Journal · 2020-02-25An Improved, Practical, and Scalable Five-Step Synthesis of PsilocybinSynthesis · 2020-01-07Enzymatic Route toward 6-Methylated Baeocystin and PsilocybinChemBioChem · 2019-05-30Novel psychotherapeutics - a cautiously optimistic focus on Hallucinogens.Expert review of clinical pharmacology · 2017-12-31Liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of multiple hallucinogens, chlorpheniramine, ketamine, ritalinic acid, and metabolites, in urine.Unknown journal · 2007-09-30Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys.Unknown journal · 2004-02-29Psilocybin and psilocin levels in twenty species from seven genera of wild mushrooms in the Pacific Northwest, U.S.A.Unknown journal · 1982-04-30Variation of psilocybin and psilocin levels with repeated flushes (harvests) of mature sporocarps of Psilocybe cubensis (Earle) Singer.Unknown journal · 1982-04-30Quantitative analysis of psilocybin and psilocin in psilocybe baeocystis (Singer and Smith) by high-performance liquid chromatography and by thin-layer chromatography.Unknown journal · 1981-02-28Psilocin, bufotenine and serotonin: historical and biosynthetic observations.Unknown journal · 1978-12-31The effect of bufotenine, melatonin, psilocybin, and related compounds on the 5-hydroxytryptamine excitatory receptors of Helix aspersa neuronsComparative and General Pharmacology · 1972-02-29